LOCALIZATION OF ANTIBODIES TO OXIDIZED LDL IN NORMAL & APOPTOTIC CELLS
正常情况下氧化 LDL 抗体的定位
基本信息
- 批准号:6469043
- 负责人:
- 金额:$ 10.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-05-01 至 2002-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We have shown through immunofluorescence and confocal microscopy
that centrosomes of high grade breast tumors are larger and more
numerous than centrosomes in normal breast tissue. Additionally, the
centrosomes in breast tumor cells are hyperphosphorylated and are
capable of nucleating a larger number of microtubules in vitro as
compared to centrosomes from normal breast cells. We describe these
centrosomes as "hypertrophic". Attempts to characterize hypertrophic
centrosomes at an ultrastructural level using CTEM have been
difficult. This is due, at least in part, to the small volume of the
centrosomes relative to the total volume of the cells; the centrosomes
are few and far between in 90 nm thick sections through cells that are
6-10 um thick. In addition, the hypertrophic centrosomes we have
observed with CTEM have been especially electron opaque, making it
difficult to resolve microtubules and other structural components of
the centrosomes. Initial results using 0.5 and 1 micron thick
sections have proven not only to greatly facilitate the locating of
hypertropic centrosomes, but have also produced 3-dimensional images
with heretofore unseen structural detail. Several tomographic
reconstructions of centrosomes from cancerous cells were performed
when Dr. Lingle visited the laboratory last summer. Additional
reconstructions are planned in the near future.
我们已经通过免疫荧光和共聚焦显微镜显示
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joseph L. Witztum其他文献
PRO-INFLAMMATORY INTERLEUKIN-1 GENOTYPES AFFECT THE ASSOCIATION OF C-REACTIVE PROTEIN FOR ANGIOGRAPHICALLY DETERMINEDCORONARY ARTERY DISEASE AND CARDIOVASCULAR EVENTS
- DOI:
10.1016/s0735-1097(17)33582-9 - 发表时间:
2017-03-21 - 期刊:
- 影响因子:
- 作者:
Aris Bechlioulis;Katerina K. Naka;Lynn Doucette-Stamm;Leon Wilkins;Aikaterini Marini;Sophia Giannitsi;John Rogus;Kenneth Kornman;Joseph L. Witztum;Sotirios Tsimikas;Lampros K. Michalis - 通讯作者:
Lampros K. Michalis
Thyroid hormone and thyrotropin levels in patients placed on colestipol hydrochloride.
服用盐酸考来替泊的患者的甲状腺激素和促甲状腺素水平。
- DOI:
- 发表时间:
1978 - 期刊:
- 影响因子:5.8
- 作者:
Joseph L. Witztum;Laurence S. Jacobs;Gustav Schonfeld - 通讯作者:
Gustav Schonfeld
A RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 STUDY OF OLEZARSEN IN PATIENTS WITH FAMILIAL CHYLOMICRONEMIA SYNDROME
- DOI:
10.1016/s0735-1097(24)03660-x - 发表时间:
2024-04-02 - 期刊:
- 影响因子:
- 作者:
Erik S.G. Stroes;Vickie Alexander;Ewa Prokopczuk;Robert Hegele;Marcello Arca;Christie M. Ballantyne;Handrean Soran;Thomas Prohaska;Shuting Xia;Henry Ginsberg;Joseph L. Witztum;Sotirios Tsimikas - 通讯作者:
Sotirios Tsimikas
EFFECT OF OLEZARSEN ON LIPOPROTEIN-ASSOCIATED APOC-III IN PATIENTS WITH FAMILIAL CHYLOMICRONEMIA SYNDROME
奥莱扎单抗对家族性乳糜微粒血症综合征患者脂蛋白相关载脂蛋白 C-III 的影响
- DOI:
10.1016/s0735-1097(25)02773-1 - 发表时间:
2025-04-01 - 期刊:
- 影响因子:22.300
- 作者:
xiaohong yang;Vickie Alexander;Thomas Prohaska;Ewa Prokopczuk;Shuting Xia;Joseph L. Witztum;Sotirios Tsimikas - 通讯作者:
Sotirios Tsimikas
RATIONALE AND DESIGN OF THE BALANCE STUDY: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY OF OLEZARSEN IN PATIENTS WITH FAMILIAL CHYLOMICRONEMIA SYNDROME
- DOI:
10.1016/s0735-1097(23)02208-8 - 发表时间:
2023-03-07 - 期刊:
- 影响因子:
- 作者:
Vickie Alexander;Ewa Prokopczuk;Erik S.G. Stroes;Christie M. Ballantyne;Henry Ginsberg;Shuting Xia;Joseph L. Witztum;Sotirios Tsimikas - 通讯作者:
Sotirios Tsimikas
Joseph L. Witztum的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joseph L. Witztum', 18)}}的其他基金
Pivotal Role of Oxidation-specific Epitopes in CVD and NASH.
氧化特异性表位在 CVD 和 NASH 中的关键作用。
- 批准号:
10461066 - 财政年份:2020
- 资助金额:
$ 10.66万 - 项目类别:
Pivotal Role of Oxidation-specific Epitopes in CVD and NASH.
氧化特异性表位在 CVD 和 NASH 中的关键作用。
- 批准号:
10683981 - 财政年份:2020
- 资助金额:
$ 10.66万 - 项目类别:
Pivotal Role of Oxidation-specific Epitopes in CVD and NASH.
氧化特异性表位在 CVD 和 NASH 中的关键作用。
- 批准号:
10262920 - 财政年份:2020
- 资助金额:
$ 10.66万 - 项目类别:
Pivotal Role of Oxidation-specific Epitopes in CVD and NASH
氧化特异性表位在 CVD 和 NASH 中的关键作用
- 批准号:
9803625 - 财政年份:2019
- 资助金额:
$ 10.66万 - 项目类别:
Program Project: Role of Innate Immunity in Atherosclerosis
计划项目:先天免疫在动脉粥样硬化中的作用
- 批准号:
8289850 - 财政年份:2008
- 资助金额:
$ 10.66万 - 项目类别:
Program Project: Role of Innate Immunity in Atherosclerosis
计划项目:先天免疫在动脉粥样硬化中的作用
- 批准号:
7851224 - 财政年份:2008
- 资助金额:
$ 10.66万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 10.66万 - 项目类别:
Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 10.66万 - 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 10.66万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 10.66万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 10.66万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 10.66万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 10.66万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 10.66万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 10.66万 - 项目类别:
Mentoring Scientists for Careers in HIV Translational Clinical Research
指导科学家从事艾滋病毒转化临床研究
- 批准号:
10762827 - 财政年份:2023
- 资助金额:
$ 10.66万 - 项目类别: